Kudo Masatoshi, Zheng Rong Qin, Kim Soo Ryang, Okabe Yoshihiro, Osaki Yukio, Iijima Hiroko, Itani Toshinao, Kasugai Hiroshi, Kanematsu Masayuki, Ito Katsuyoshi, Usuki Norio, Shimamatsu Kazuhide, Kage Masayoshi, Kojiro Masamichi
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
Intervirology. 2008;51 Suppl 1:17-26. doi: 10.1159/000122595. Epub 2008 Jun 10.
To evaluate the diagnostic accuracy of liver cirrhosis by imaging modalities, including CT, MRI and US, compared to results obtained from histopathological diagnoses of resected specimens.
CT, MRI and US examinations of 142 patients with chronic liver disease who underwent surgery for complicated hepatocellular carcinoma (<3 cm in diameter) in 10 institutions were blindly reviewed in a multicenter study by three radiologists experienced in CT, MRI and US. The images were evaluated for five imaging parameters (irregular or nodular liver surface, blunt liver edge, liver parenchymal abnormalities, liver morphological changes and manifestations of portal hypertension) using a severity scale. The diagnostic imaging impression score was also calculated. Patients were histologically classified into chronic hepatitis (CH; n = 54), liver cirrhosis (LC; n = 71) and pre-cirrhosis (P-LC; n = 17) by three pathologists, independently, who reviewed the resected liver specimens. The results of the three imaging methods were compared to those from histological diagnoses, and a multivariate analysis (stepwise forward logistic regression analysis) was performed to identify independent predictive signs of cirrhosis. The diagnostic efficacies for LC and early cirrhosis were also compared among CT, MRI and US using a receiver-operating characteristic (ROC) curve analysis.
The differences in the five imaging parameters evaluated by CT, MRI and US between LC and CH were statistically significant (p < 0.001) except for the manifestations of portal hypertension on US. Irregular or nodular surface, blunt edge or morphological changes in the liver were selected as the best predictive signs for cirrhosis on US whereas liver parenchymal abnormalities, manifestations of portal hypertension and morphological changes in the liver were the best predictive signs on MRI and CT by multivariate analysis. The predictive diagnostic accuracy, sensitivity and specificity in discriminating LC from CH based on the best predictive signs were 71.9, 77.1 and 67.6% by CT; 67.9, 67.5 and 68.3% by MRI, and 66.0, 38.4 (lower than CT and MRI, p =0.001) and 88.8% (higher than CT and MRI, p =0.001)by US. According to the imaging impression scoring system, diagnostic accuracy, sensitivity and specificity were 67.0, 84.3 and 52.9% by CT; 70.3, 86.7 and 53.9% by MRI, and 64.0, 52.4 (lower than CT and MRI, p =0.0001) and 73.5% (higher than CT and MRI, p < 0.003) by US. ROC analysis showed that MRI and CT were slightly superior to US in the diagnosis of LC but no statistically significant difference was found between them. For the pathological diagnosis of P-LC, cirrhosis was diagnosed in 59.5, 46.7 and 41.7% of the P-LC cases by US, CT and MRI, respectively, with no significant difference among these methods.
US, CT and MRI had different independent predictive signs for the diagnosis of LC. MRI and CT were slightly superior to US in predicting cirrhosis, especially regarding sensitivity. Noninvasive imaging techniques play an important role in the diagnosis of cirrhosis, especially in the evaluation of P-LC.
与切除标本的组织病理学诊断结果相比,评估包括CT、MRI和超声在内的成像方式对肝硬化的诊断准确性。
在一项多中心研究中,由三位分别擅长CT、MRI和超声的放射科医生对10家机构中142例因直径<3 cm的复杂性肝细胞癌接受手术的慢性肝病患者的CT、MRI和超声检查进行盲法评估。使用严重程度量表对图像的五个成像参数(肝脏表面不规则或呈结节状、肝边缘钝圆、肝实质异常、肝脏形态改变和门静脉高压表现)进行评估。还计算了诊断成像印象评分。由三位病理学家独立对切除的肝脏标本进行组织学分类,分为慢性肝炎(CH;n = 54)、肝硬化(LC;n = 71)和肝硬化前期(P-LC;n = 17)。将三种成像方法的结果与组织学诊断结果进行比较,并进行多变量分析(逐步向前逻辑回归分析)以确定肝硬化的独立预测征象。还使用受试者操作特征(ROC)曲线分析比较了CT、MRI和超声对LC和早期肝硬化的诊断效能。
除超声检查的门静脉高压表现外,CT、MRI和超声评估的LC与CH之间的五个成像参数差异具有统计学意义(p < 0.001)。多变量分析显示,肝脏表面不规则或呈结节状、边缘钝圆或形态改变是超声诊断肝硬化的最佳预测征象,而肝实质异常、门静脉高压表现和肝脏形态改变是MRI和CT诊断肝硬化的最佳预测征象。基于最佳预测征象区分LC与CH的预测诊断准确性、敏感性和特异性,CT分别为71.9%、77.1%和67.6%;MRI分别为67.9%、67.5%和68.3%;超声分别为66.0%、38.4%(低于CT和MRI,p = 0.001)和88.8%(高于CT和MRI,p = 0.001)。根据成像印象评分系统,CT的诊断准确性、敏感性和特异性分别为67.0%、84.3%和52.9%;MRI分别为70.3%、86.7%和53.9%;超声分别为64.0%、52.4%(低于CT和MRI,p = 0.0001)和73.5%(高于CT和MRI,p < 0.003)。ROC分析显示,MRI和CT在LC诊断方面略优于超声,但两者之间无统计学显著差异。对于P-LC的病理诊断,超声、CT和MRI分别在59.5%、46.7%和41.7%的P-LC病例中诊断出肝硬化,这些方法之间无显著差异。
超声、CT和MRI在LC诊断方面具有不同的独立预测征象。MRI和CT在预测肝硬化方面略优于超声,尤其是在敏感性方面。非侵入性成像技术在肝硬化诊断中发挥着重要作用,尤其是在P-LC的评估中。